LAP3 and rheumatoid arthritis: Several peptidase inhibitors have been characterised and studied in human diseases, such as acquired immune deficiency syndrome (AIDS), Alzheimer’s, osteoporosis, cardiovascular diseases, rheumatoid arthritis, cancer, obesity, and others12,.39–42